TrialBreast cancer research and treatment2024

A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.

Ozge Gumusay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.